Home / Clinical Decision Support & Reference / PeraServer and PeraTrend

PeraServer and PeraTrend

by PeraHealth · Based in United States → — Predictive analytics for early detection of patient deterioration.

Critical Care Emergency Medicine Hospital Medicine

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Contact for pricing

Regulatory Status Disclosed

Overview

PeraHealth, now part of Spacelabs Healthcare, develops predictive enterprise software powered by the Rothman Index (RI). The Rothman Index is a statistically validated patient acuity score that continuously measures a patient’s physiological condition by synthesizing routine vital signs, nursing assessments, and lab results from the Electronic Health Record (EHR). PeraServer computes the Rothman Index scores and configurable warnings, while PeraTrend provides a web-based user interface for real-time trending and review of these scores and underlying data. This system provides clinicians with a visual dashboard of a patient’s condition, helping to detect subtle changes before they become life-threatening and enabling earlier intervention.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Rothman Index patient acuity score
Real-time predictive analytics
Visual dashboard for patient condition (PeraTrend)
EHR integration
Early detection of patient deterioration
Continuous patient monitoring
Configurable warning states
Supports neonatal, pediatric, and adult patients
PeraMobile interactive mobile application

Use Cases

Reduce in-hospital mortality rates
Decrease unplanned transfers to the ICU
Facilitate timely palliative care consults
Identify at-risk patients sooner for earlier intervention
Improve overall patient safety and outcomes
Optimize ICU bed utilization

What Physicians Need to Know

Evidence Base

PeraServer and PeraTrend are powered by the Rothman Index (RI), a validated, disease-agnostic, continuous measure of patient condition. The RI is calculated from commonly recorded vital signs, nursing assessments, and lab data from Electronic Health Records (EHRs). The underlying model is supported by over 40 peer-reviewed articles.

Clinical Validation Studies

The Rothman Index has undergone extensive validation, including FDA 510(k) clearance. Studies have shown the RI to be strongly associated with the risk of unplanned hospital readmissions, with high-risk patients being more than 2.5 times as likely to be readmitted. Clinical results from its use include reported reductions in mortality rates by as much as 30 percent. The Rothman Index score is validated for use with neonatal, pediatric, and adult patients across various hospital settings.

Alert Fatigue Management

PeraHealth's solutions, including PeraMobile (a related product), offer organizational configuration options that allow clinicians to determine when to receive notifications, such as push notifications, to help reduce alarm fatigue and build trust in the system.

Override Rate Data

Specific override rate data for PeraServer and PeraTrend is not explicitly detailed in the available information. General studies on clinical decision support systems indicate override rates can vary widely, often ranging from 49% to 94%.

Clinical Workflow Integration

PeraServer collects demographic and clinical data from EHR and ancillary systems, while PeraTrend provides a web-based user interface for trending and review of Rothman Index scores. The system is designed to interface with major EHR vendors and other medical automation systems, allowing for seamless integration into existing clinical workflows at both the nursing unit and system-wide surveillance levels. It automatically calculates scores from existing EHR data without requiring manual input.

Physician Tip

Leverage PeraTrend's real-time visual dashboard and the Rothman Index to proactively identify subtle patient deterioration across all care settings and patient populations (neonatal, pediatric, adult). Customize notification thresholds to minimize alert fatigue and focus on high-priority patients. Integrate PeraTrend into daily rounds and handoffs to facilitate communication and enhance early intervention strategies, potentially reducing readmissions and improving patient outcomes. Utilize the system's ability to pull data directly from the EHR to gain insights without additional manual input.

PeraServer and PeraTrend are designed for robust integration with existing hospital Electronic Health Record (EHR) systems and other medical automation platforms. The system automatically extracts vital signs, lab results, and nursing assessments, making it compatible with major EHR vendors. This allows for real-time data flow and display, supporting clinical decision-making within the established IT infrastructure.

At a glance

Pricing Contact for pricing

Deployment Web Based User Interface, Integrated Into EHR, Dedicated Kiosk Display, Software Only Devices Installed On User Provided Hardware.

Visit site

Details

Category	Clinical Decision Support & Reference, Triage & ER/ICU AI
Pricing	Contact for pricing
Deployment	Web-based user interface, integrated into EHR, dedicated kiosk display, software-only devices installed on user-provided hardware.
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	1 AI-estimated PeraServer and PeraTrend System (K172959) received FDA clearance on 05/01/2018. The Rothman Index is indicated for use by healthcare providers for displaying and trending RI scores and associated configurable warning states as an adjunct to clinical decision support in hospital settings.
Integrations
EHR	Not specified
Specialties	Critical Care, Emergency Medicine, Hospital Medicine

What the Web Says

PeraServer and PeraTrend are healthcare technologies developed by PeraHealth, utilizing the Rothman Index (RI) to provide real-time clinical surveillance and aid in early detection of patient deterioration. The system integrates with Electronic Health Records (EHRs) and offers web-based interfaces for trending and reviewing patient data. It has received FDA 510(k) clearance, indicating it is at least as safe and effective as legally marketed devices.

Overall: Positive

Strengths

Real-time clinical surveillance for early detection of patient deterioration.
Utilizes the statistically validated Rothman Index (RI) for a continuous measure of patient condition across various diseases and care levels.
Integrates with existing Electronic Health Records (EHRs).
Web-based user interface for trending and review of RI scores and underlying data.
Validated for use with neonatal, pediatric, and adult patients.
Shown to reduce hospital mortality in clinical trials.

Limitations

No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
The system is an adjunct to clinical decision support and not intended to replace vital signs monitoring or for use in the Neonatal Intensive Care Unit.

Based on reviews from: accessdata.fda.gov, pharmaphorum, Forbes

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate PeraServer and PeraTrend

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

DOTmed

Spacelabs Healthcare acquires predictive analytics company PeraHealth

Spacelabs Healthcare acquired PeraHealth, developer of the Rothman Index, a predictive enterprise software that quantifies and alerts clinicians to patient deterioration in real time. This acquisition aims to enhance Spacelabs' clinical informatics with PeraHealth's analytics to improve patient outcomes and reduce costs.

2023-02

MrWeb

Spacelabs Buys Predictive Analytics Firm PeraHealth

Medical equipment and services provider Spacelabs Healthcare has acquired predictive analytics company PeraHealth for an undisclosed sum. PeraHealth's Rothman Index is noted as the only FDA-cleared predictive analytics solution of its kind.

2023-03

Research Live

Spacelabs acquires predictive analytics business

Spacelabs Healthcare has acquired PeraHealth, a company that develops predictive enterprise software based on the Rothman Index to quantify patient acuity. This integration is expected to help healthcare organizations achieve better outcomes and lower costs.

2023-03

Spacelabs Healthcare

PeraHealth joins the Spacelabs family

PeraHealth has joined the Spacelabs Healthcare family, expanding Spacelabs' clinical informatics with the predictive analytics of PeraHealth's Rothman Index. These solutions are designed to alert clinicians to patient deterioration, aiming to reduce in-hospital mortality and unplanned ICU transfers.

2023-03

pharmaphorum

FDA clears PeraHealth's lifesaving clinical surveillance tech

PeraHealth's PeraTrend, a predictive real-time clinical surveillance technology, received 510(k) clearance from the FDA, making it the first solution of its kind to achieve this. The technology uses the Rothman Index to monitor patient health and identify anomalies.

2018-05

PeraHealth (via PR Newswire)

PeraHealth receives U.S. FDA 510(k) clearance for industry-leading clinical surveillance technology

PeraHealth announced that its PeraTrend clinical surveillance technology received 510(k) clearance from the FDA, a significant milestone for the company and the clinical surveillance market. PeraTrend, powered by the Rothman Index, leverages EHR data to quantify and visualize patient deterioration.

2018-05

FDA

510(k) Premarket Notification - PeraServer and PeraTrend

This FDA document details the 510(k) Premarket Notification for PeraServer and PeraTrend by Perahealth, Inc. It outlines the intended use of PeraServer for generating Rothman Index scores and PeraTrend for displaying and trending these scores as an adjunct to clinical decision support for healthcare providers.

2018-05

Becker's Hospital Review

Froedtert taps PeraHealth for clinical surveillance, predictive analytics

Froedtert & the Medical College of Wisconsin planned to deploy PeraHealth's predictive analytics solutions, including PeraTrend and PeraAnalytics, across its network in early 2018. These solutions aim to support early detection of physiological changes and improve capacity management.

2018-01

Videos

Product demos, reviews, and walkthroughs for PeraServer and PeraTrend.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

How does PeraServer and PeraTrend integrate into our existing clinical workflows and Electronic Health Record (EHR) system?

PeraServer collects specified demographic and clinical data directly from your EHR and other ancillary systems. PeraTrend then provides a web-based user interface for viewing and trending Rothman Index (RI) scores and warnings, which can be accessed via a web browser, integrated into the EHR, or displayed on dedicated kiosks.

Is PeraServer and PeraTrend HIPAA compliant, and how is patient data secured?

Yes, PeraServer and PeraTrend are explicitly stated to be HIPAA compliant. PeraServer collects specified demographic and clinical data from the EHR, and the system is designed to handle this sensitive information securely, adhering to medical device reporting requirements.

What are the key clinical benefits of using PeraServer and PeraTrend, and what are its limitations or intended uses?

PeraTrend provides clinicians with a real-time visual dashboard of a patient's condition using the Rothman Index (RI), helping to detect subtle, potentially life-threatening changes earlier. It is intended as an adjunct to clinical decision support for neonatal, pediatric, and adult patients in hospital settings, not as a replacement for vital signs monitoring or for use in the Neonatal Intensive Care Unit.

How accurate is the Rothman Index (RI) in predicting patient deterioration, and what data does it utilize?

The Rothman Index is a single measure of a patient's physiological condition based on the aggregate statistical mortality risk associated with vital signs, nursing assessments, and selected lab values. It is designed to detect deterioration earlier, often with less than 24 hours' warning and minimal false alerts, by continuously computing patient acuity from existing EHR data.

How does PeraServer and PeraTrend compare to other early warning systems or predictive analytics tools in healthcare?

PeraServer and PeraTrend leverage the proprietary Rothman Index, which is described as the only general measure of patient condition, utilizing existing, real-time EHR data to quantify and visualize patient acuity and risk. While specific comparisons to other systems are not detailed in the provided information, its FDA 510(k) clearance indicates it meets regulatory standards for medical devices.

What is the typical pricing model or cost structure for implementing and using PeraServer and PeraTrend?

Specific pricing models for PeraServer and PeraTrend are not publicly disclosed in the available information. Typically, healthcare AI solutions like this involve enterprise-level licensing agreements, which are negotiated directly with the vendor based on factors such as hospital size, number of beds, and desired features.

Compare PeraServer and PeraTrend

BriefCase vs PeraServer and PeraTrend

Clinical Decision Support & Reference Adjacent · 65/100

BriefCase focuses on AI-powered communication and collaboration for critical medical imaging findings, primarily for radiologists and care teams to streamline the sharing and prioritization of urgent cases from…

OpenEvidence vs PeraServer and PeraTrend

Clinical Decision Support & Reference Adjacent · 65/100

OpenEvidence focuses on providing evidence-based answers to clinical questions and assisting with documentation, making it suitable for point-of-care reference and note generation. PeraServer and PeraTrend, on the other…

eCARTv5 Clinical Deterioration Suite (eCART) vs PeraServer and PeraTrend

Clinical Decision Support & Reference Direct · 95/100

Both AgileMD's eCARTv5 and PeraHealth's PeraServer/PeraTrend are FDA-cleared, AI-powered Software as a Medical Device (SaMD) designed to predict clinical deterioration in hospitalized patients. While eCARTv5 focuses on predicting…